Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/6845
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSYLVESTER, Richard-
dc.contributor.authorvan der Meijden, A.P.M.-
dc.contributor.authorOosterlinck, W.-
dc.contributor.authorHoeltl, W.-
dc.contributor.authorBono, A.-
dc.date.accessioned2007-12-20T16:10:58Z-
dc.date.available2007-12-20T16:10:58Z-
dc.date.issued2003-
dc.identifier.citationEuropean urology, 44. p. 423-428-
dc.identifier.issn0302-2838-
dc.identifier.urihttp://hdl.handle.net/1942/6845-
dc.language.isoen-
dc.titleThe side effects of Bacillus Calmette-Guerin in the treatment of TaT1 bladder cancer do not predict its efficacy: results form a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial-
dc.typeJournal Contribution-
dc.identifier.epage428-
dc.identifier.spage423-
dc.identifier.volume44-
local.bibliographicCitation.jcatA1-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.bibliographicCitation.oldjcatA1-
dc.identifier.doi10.1016/S0302-2838(03)00371-3-
dc.identifier.isi000185902800006-
item.fullcitationSYLVESTER, Richard; van der Meijden, A.P.M.; Oosterlinck, W.; Hoeltl, W. & Bono, A. (2003) The side effects of Bacillus Calmette-Guerin in the treatment of TaT1 bladder cancer do not predict its efficacy: results form a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial. In: European urology, 44. p. 423-428.-
item.fulltextNo Fulltext-
item.contributorSYLVESTER, Richard-
item.contributorvan der Meijden, A.P.M.-
item.contributorOosterlinck, W.-
item.contributorHoeltl, W.-
item.contributorBono, A.-
item.accessRightsClosed Access-
crisitem.journal.issn0302-2838-
crisitem.journal.eissn1873-7560-
Appears in Collections:Research publications
Show simple item record

SCOPUSTM   
Citations

75
checked on Apr 29, 2026

WEB OF SCIENCETM
Citations

64
checked on May 1, 2026

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.